Levetiracetam Differentially Alters CD95 Expression of Neuronal Cells and the Mitochondrial Membrane Potential of Immune and Neuronal Cells in vitro

Epilepsy is a neurological seizure disorder that affects over 100 million people worldwide. Levetiracetam, either alone, as monotherapy, or as adjunctive treatment, is widely used to control certain types of seizures. Despite its increasing popularity as a relatively safe and effective anti-convulsi...

Descripción completa

Detalles Bibliográficos
Autores principales: Rogers, Susannah K., Shapiro, Lee A., Tobin, Richard P., Tow, Benjamin, Zuzek, Aleksej, Mukherjee, Sanjib, Newell-Rogers, M. Karen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3927234/
https://www.ncbi.nlm.nih.gov/pubmed/24600432
http://dx.doi.org/10.3389/fneur.2014.00017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3927234/
https://www.ncbi.nlm.nih.gov/pubmed/24600432
http://dx.doi.org/10.3389/fneur.2014.00017

Ejemplares similares